FBLG
FibroBiologics, Inc. Common Stock
NASDAQ: FBLG · HEALTHCARE · BIOTECHNOLOGY
$1.32
+0.76% today
Updated 2026-04-30
Market cap
$6.45M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.40
Dividend yield
—
52W range
$1 – $23
Volume
1.0M
FibroBiologics, Inc. Common Stock (FBLG) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+11.2%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-566.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+2.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+5.8%
2026-02-25
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $-0.60 | +70.0% | $0.27 | $0.28 | +5.8% |
| 2025-10-31 | $-0.13 | -13.0% | $0.40 | $0.39 | -0.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-2.00 | $-0.60 | +70.0% | — | — |
| 2025-09-30 | $-0.12 | $-0.13 | -13.0% | — | — |
| 2025-06-30 | $-0.12 | $-0.12 | +0.0% | — | — |
| 2025-03-31 | $-0.13 | $-0.14 | -12.0% | — | — |
| 2024-12-31 | $-0.09 | $-0.09 | +0.0% | $554000.00 | — |
| 2024-09-30 | $-0.09 | $-0.01 | +88.9% | — | — |
| 2024-06-30 | $-0.09 | $-0.02 | +77.8% | — | — |
| 2024-03-31 | — | $-0.27 | — | — | — |
Frequently asked questions
Has FibroBiologics, Inc. Common Stock beaten earnings estimates?
FibroBiologics, Inc. Common Stock has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +11.2% over the last 4 quarters.
How does FBLG stock react to earnings?
FBLG stock has moved an average of +2.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.